News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
587,385 Results
Type
Article (19822)
Company Profile (168)
Press Release (567393)
Multimedia
Podcasts (81)
Webinars (14)
Section
Business (200354)
Career Advice (724)
Deals (31060)
Drug Delivery (88)
Drug Development (66367)
Employer Resources (55)
FDA (12563)
Job Trends (11253)
News (290846)
Policy (24545)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Genetown Elite (1)
2027 Genetown Standard (3)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (5)
Academia (887)
Accelerated approval (40)
ADA (27)
Adcomms (10)
Allergies (149)
Alliances (42263)
ALS (146)
Alzheimer's disease (1282)
Antibody-drug conjugate (ADC) (350)
Approvals (13179)
Artificial intelligence (507)
ASCO (224)
Autoimmune disease (248)
Automation (40)
Bankruptcy (321)
Best Places to Work (8487)
BIO (47)
BIOSECURE Act (11)
Biosimilars (187)
Biotechnology (106)
Bladder cancer (150)
Brain cancer (56)
Breast cancer (601)
Cancer (4507)
Cardiovascular disease (354)
Career advice (627)
Career pathing (14)
CAR-T (217)
CDC (9)
Celiac Disease (1)
Cell therapy (618)
Cervical cancer (41)
Clinical research (59404)
Collaboration (1709)
Commercialization (2)
Company closure (1)
Compensation (1426)
Complete response letters (61)
COVID-19 (1376)
CRISPR (86)
C-suite (1035)
Cystic fibrosis (126)
Data (6672)
Decentralized trials (1)
Denatured (26)
Depression (130)
Dermatology (68)
Diabetes (447)
Diagnostics (4916)
Digital health (44)
Diversity (3)
Diversity, equity & inclusion (16)
Drug discovery (263)
Drug pricing (128)
Drug shortages (15)
Duchenne muscular dystrophy (225)
Earnings (81398)
Editorial (28)
Employer branding (5)
Employer resources (51)
Events (100137)
Executive appointments (953)
FDA (15697)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (19)
Frontotemporal dementia (28)
Funding (1232)
Gene editing (171)
Generative AI (36)
Gene therapy (475)
GLP-1 (677)
Government (2133)
Grass and pollen (5)
Guidances (339)
Healthcare (11431)
Hematology (130)
HIV (64)
Huntington's disease (29)
IgA nephropathy (95)
Immunology and inflammation (167)
Immuno-oncology (77)
Indications (193)
Infectious disease (1611)
Inflammatory bowel disease (173)
Inflation Reduction Act (9)
Influenza (97)
Intellectual property (291)
Interviews (98)
IPO (14137)
IRA (33)
Job creations (3141)
Job search strategy (566)
JPM (31)
Kidney cancer (20)
Labor market (39)
Layoffs (252)
Leadership (11)
Legal (6647)
Liver cancer (56)
Longevity (22)
Lung cancer (629)
Lymphoma (339)
Machine learning (37)
Management (19)
Manufacturing (897)
Marketing (10)
MASH (168)
Medical affairs (1)
Medical device (9448)
Medtech (9585)
Mergers & acquisitions (18078)
Metabolic disorders (1073)
mRNA (111)
Multiple sclerosis (139)
NASH (15)
Neurodegenerative disease (298)
Neuropsychiatric disorders (71)
Neuroscience (2443)
Neurotech (1)
NextGen: Class of 2026 (3993)
Non-profit (1368)
Now hiring (26)
Obesity (428)
Opinion (162)
Ovarian cancer (179)
Pain (244)
Pancreatic cancer (227)
Parkinson's disease (276)
Partnered (20)
Patents (569)
Patient recruitment (587)
Peanut (42)
People (51080)
Pharmaceutical (45)
Pharmacy benefit managers (23)
Phase 1 (18345)
Phase 2 (26130)
Phase 3 (19369)
Pipeline (8191)
Policy (167)
Postmarket research (2143)
Preclinical (7598)
Press Release (57)
Prostate cancer (238)
Psychedelics (30)
Radiopharmaceuticals (268)
Rare diseases (849)
Real estate (4570)
Recruiting (20)
Regulatory (19944)
Reports (25)
Research institute (1014)
Resumes & cover letters (96)
Rett syndrome (40)
RNA editing (12)
RSV (52)
Schizophrenia (145)
Series A (221)
Series B (158)
Service/supplier (4)
Sickle cell disease (98)
Special edition (11)
Spinal muscular atrophy (115)
Sponsored (15)
Startups (2814)
State (2)
Stomach cancer (8)
Supply chain (95)
Tariffs (71)
The Weekly (53)
Vaccines (552)
Venture capital (55)
Weight loss (227)
Women's health (96)
Worklife (4)
Date
Today (86)
Last 7 days (360)
Last 30 days (1460)
Last 365 days (23540)
2026 (13542)
2025 (23688)
2024 (27716)
2023 (31861)
2022 (41234)
2021 (43924)
2020 (40406)
2019 (30229)
2018 (23087)
2017 (25081)
2016 (24002)
2015 (29904)
2014 (25968)
2013 (22319)
2012 (24320)
2011 (24707)
2010 (23866)
Location
Africa (485)
Alabama (79)
Alaska (2)
Arizona (323)
Arkansas (13)
Asia (30514)
Australia (4251)
California (12301)
Canada (3377)
China (1022)
Colorado (493)
Connecticut (447)
Delaware (269)
Europe (57812)
Florida (1864)
Georgia (392)
Hawaii (3)
Idaho (49)
Illinois (846)
India (88)
Indiana (544)
Iowa (16)
Japan (549)
Kansas (117)
Kentucky (36)
Louisiana (29)
Maine (27)
Maryland (1363)
Massachusetts (8492)
Michigan (318)
Minnesota (594)
Mississippi (5)
Missouri (101)
Montana (27)
Nebraska (16)
Nevada (114)
New Hampshire (70)
New Jersey (3124)
New Mexico (18)
New York (3060)
North Carolina (1492)
North Dakota (4)
Northern California (6131)
Ohio (301)
Oklahoma (16)
Oregon (28)
Pennsylvania (2470)
Puerto Rico (26)
Rhode Island (36)
South America (751)
South Carolina (78)
South Dakota (1)
Southern California (5063)
Tennessee (143)
Texas (1963)
United States (41918)
Utah (373)
Vermont (1)
Virginia (260)
Washington D.C. (52)
Washington State (957)
West Virginia (2)
Wisconsin (103)
Wyoming (1)
587,385 Results for "king pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
AviadoBio Expands vMiX™ Precision Gene Silencing Platform Exclusive License Agreement with King’s College London Beyond Neurological Diseases to All Human Therapeutic Areas
June 16, 2026
·
5 min read
Antibody-drug conjugate (ADC)
ASCO: Merck overshadowed by upstart biotechs but TROP2 plans begin to pay off
Merck may not have had the splashiest presentation at the American Society of Clinical Oncology meeting, but the data show why the Big Pharma remains king of oncology, analysts say.
June 2, 2026
·
4 min read
·
Annalee Armstrong
Immuno-oncology
ASCO: Summit reached with China lung data but new climb begins to prove global benefit
“King Keytruda’s reign continues,” analysts at BMO Capital Markets declared after Chinese data for Summit Therapeutics’ ivonescimab were revealed at the American Society for Clinical Oncology in Chicago.
June 1, 2026
·
3 min read
·
Annalee Armstrong
Press Releases
Universe Pharmaceuticals INC Announces Strategic Acquisition to Expand Pharmaceutical Patent Portfolio
June 28, 2026
·
5 min read
Press Releases
Septa Pharmaceuticals Inc. Acquires CeeNU® (Lomustine) from Bristol Myers Squibb, Canada
July 15, 2026
·
2 min read
Press Releases
Phio Pharmaceuticals Announces Participation in the Life Sciences Investor Forum on June 24-25, 2026
The Company invites individual and institutional investors, as well as advisors and analysts with an interest in Phio Pharmaceuticals, to attend the live, interactive presentation and one-on-one meetings
June 18, 2026
·
5 min read
Artificial intelligence
Alnylam hops on AI train with up to $2B Inceptive partnership
Alnylam Pharmaceuticals will leverage Inceptive Nucleics’ generative machine learning models to accelerate the development of RNA interference therapies.
June 4, 2026
·
1 min read
·
Tristan Manalac
Business
TFF Pharmaceuticals Appoints Thomas B. King to Board of Directors
TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing (TFF) technology platform, today announced the appointment of Thomas B. King to its Board of Directors.
December 13, 2023
·
5 min read
Press Releases
Merck Completes Acquisition of Terns Pharmaceuticals, Inc.
May 5, 2026
·
6 min read
Press Releases
NRx Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
June 3, 2026
·
5 min read
1 of 58,739
Next
